CEO Geert Kersten buys CEL-SCI (CVM) stock at $5.26 in Form 4

Rhea-AI Filing Summary

CEL-SCI Corp's Chief Executive Officer and director Geert Kersten purchased 38,023 shares of the company’s common stock on January 22, 2026 at $5.26 per share.

According to the filing, these were shares of restricted stock bought directly from the company at the closing price on January 21, 2026, which was the most recent closing price available. After this transaction, Kersten directly owns 120,815 shares of CEL-SCI common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KERSTEN GEERT R

(Last) (First) (Middle)

8229 BOONE BLVD

STE 802

(Street)

VIENNA VA 22182

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/22/2026		P		38,023(1)	A	$5.26	120,815	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On January 22, 2026, Mr. Kersten purchased 38,023 shares of restricted stock directly from the Company at the closing price on January 21, 2026, the most recent closing price available.

	Geert Kersten	01/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CEL-SCI (CVM) report in this Form 4?

The filing reports that Chief Executive Officer and director Geert Kersten purchased 38,023 shares of CEL-SCI common stock on January 22, 2026.

At what price did CEL-SCI CEO Geert Kersten buy the CVM shares?

Geert Kersten bought the 38,023 shares at $5.26 per share, which was the company’s closing stock price on January 21, 2026.

How many CEL-SCI (CVM) shares does Geert Kersten own after this transaction?

Following the reported purchase, Geert Kersten directly owns 120,815 shares of CEL-SCI common stock.

What type of CEL-SCI shares did the CEO purchase in this Form 4?

The transaction involved 38,023 shares of restricted common stock, purchased directly from CEL-SCI Corporation.

What is the role of the reporting person in CEL-SCI (CVM)?

The reporting person, Geert Kersten, serves as both a director and the Chief Executive Officer of CEL-SCI Corporation.

On what date did CEL-SCI’s CEO complete the reported stock purchase?

The purchase of 38,023 restricted shares by CEO Geert Kersten was completed on January 22, 2026.